Boston Biomedical, a Norwood, MA-based biotech startup focused on cancer drugs, has raised $2 million in equity financing, according to an SEC filing. Li Chiang, the CEO and founder of Boston Biomedical, was not immediately available for comment this afternoon. It’s unclear who invested in the round. The company in April issued a press release that said it was developing a drug that targeted stem-like properties of certain cancer cells.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
